Unknown

Dataset Information

0

Traumatic Brain Injury: Oxidative Stress and Novel Anti-Oxidants Such as Mitoquinone and Edaravone.


ABSTRACT: Traumatic brain injury (TBI) is a major health concern worldwide and is classified based on severity into mild, moderate, and severe. The mechanical injury in TBI leads to a metabolic and ionic imbalance, which eventually leads to excessive production of reactive oxygen species (ROS) and a state of oxidative stress. To date, no drug has been approved by the food and drug administration (FDA) for the treatment of TBI. Nevertheless, it is thought that targeting the pathology mechanisms would alleviate the consequences of TBI. For that purpose, antioxidants have been considered as treatment options in TBI and were shown to have a neuroprotective effect. In this review, we will discuss oxidative stress in TBI, the history of antioxidant utilization in the treatment of TBI, and we will focus on two novel antioxidants, mitoquinone (MitoQ) and edaravone. MitoQ can cross the blood brain barrier and cellular membranes to accumulate in the mitochondria and is thought to activate the Nrf2/ARE pathway leading to an increase in the expression of antioxidant enzymes. Edaravone is a free radical scavenger that leads to the mitigation of damage resulting from oxidative stress with a possible association to the activation of the Nrf2/ARE pathway as well.

SUBMITTER: Ismail H 

PROVIDER: S-EPMC7601591 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Traumatic Brain Injury: Oxidative Stress and Novel Anti-Oxidants Such as Mitoquinone and Edaravone.

Ismail Helene H   Shakkour Zaynab Z   Tabet Maha M   Abdelhady Samar S   Kobaisi Abir A   Abedi Reem R   Nasrallah Leila L   Pintus Gianfranco G   Al-Dhaheri Yusra Y   Mondello Stefania S   El-Khoury Riyad R   Eid Ali H AH   Kobeissy Firas F   Salameh Johnny J  

Antioxidants (Basel, Switzerland) 20201001 10


Traumatic brain injury (TBI) is a major health concern worldwide and is classified based on severity into mild, moderate, and severe. The mechanical injury in TBI leads to a metabolic and ionic imbalance, which eventually leads to excessive production of reactive oxygen species (ROS) and a state of oxidative stress. To date, no drug has been approved by the food and drug administration (FDA) for the treatment of TBI. Nevertheless, it is thought that targeting the pathology mechanisms would allev  ...[more]

Similar Datasets

| S-EPMC8508668 | biostudies-literature
| S-EPMC2603294 | biostudies-literature
| S-EPMC6593265 | biostudies-literature
| S-EPMC4536297 | biostudies-literature
| S-EPMC7786997 | biostudies-literature
| S-EPMC3996315 | biostudies-literature
| S-EPMC7390826 | biostudies-literature
| S-EPMC4834940 | biostudies-other
2024-04-16 | GSE253476 | GEO
| S-EPMC7294631 | biostudies-literature